Type III autoimmune polyglandular syndrome: association between Type 1 Diabetes mellitus and Hashimoto thyroiditis
DOI:
https://doi.org/10.33448/rsd-v10i3.13094Keywords:
Type III autoimmune polyglandular syndrome; Type 1 Diabetes Mellitus; Hashimoto's thyroiditis; Hyperprolactinemia and Gilbert's syndrome.Abstract
Autoimmune polyglandular syndromes (APSS) are associations of two or more endocrine diseases of autoimmune origin that affect between 5-10% of the population. The grouping of these diseases depends on genetic and environmental factors, their different presentations allow the distinction of the subtypes of APS. The objective is to report the case of a patient with type III A polyglandular autoimmune syndrome, characterized by Hashimoto's thyroiditis and type 1 diabetes mellitus associated with hyperprolactinemia and Gilbert's syndrome. The patient began to show the symptoms of the syndrome at the age of 10 progressively. The treatment of each disease is being carried out, with no specific treatment for the syndrome in the literature.
References
Borba, V. V., Zandman-Goddard, G., & Shoenfeld, Y. (2018). Prolactin and autoimmunity. Frontiers in Immunology, 9(FEB), 1–8. https://doi.org/10.3389/fimmu.2018.00073
Brenta, G., Vaisman, M., Sgarbi, J. A., Bergoglio, L. M., de Andrada, N. C., Bravo, P. P., Orlandi, A. M., & Graf, H. (2013). Diretrizes clínicas práticas para o manejo do hipotiroidismo. Arquivos Brasileiros de Endocrinologia e Metabologia, 57(4), 265–298. https://doi.org/10.1590/S0004-27302013000400003
Czyzyk, A., & Kurzawa, R. (2019). Hyperprolactinemia associated with macroprolactinoma in a 17-year-old: A case report. Case Reports in Women’s Health, 22, e00111. https://doi.org/10.1016/j.crwh.2019.e00111
Dittmar, M., & Kahaly, G. J. (2010). Genetics of the autoimmune polyglandular syndrome type 3 variant. Thyroid : Official Journal of the American Thyroid Association, 20(7), 737–743. https://doi.org/10.1089/thy.2010.1639
Eira, C., Mota, Â., Silvério, R., Monteiro, R., Bastos, M., & Monteiro, A. (2017). Caso Clínico Síndrome Poliglandular Autoimune Tipo III. Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo, 12(2), 200–205.
Fernandes, A. P. M., Maciel, L. M. Z., Foss, M. C., & Donadi, E. A. (2003). Como entender a associação entre o sistema HLA e as doenças auto-imunes endócrinas. Arquivos Brasileiros de Endocrinologia & Metabologia, 47(5), 601–611. https://doi.org/10.1590/s0004-27302003000500015
Gross, J. L., Silveiro, S. P., Camargo, J. L., Reichelt, A. J., & Azevedo, M. J. de. (2002). Diabetes Melito: Diagnóstico, Classificação e Avaliação do Controle Glicêmico. Arquivos Brasileiros de Endocrinologia & Metabologia, 46(1), 16–26. https://doi.org/10.1590/s0004-27302002000100004
Hansen, M. P., Matheis, N., & Kahaly, G. J. (2015). Type 1 diabetes and polyglandular autoimmune syndrome: A review. World Journal of Diabetes, 6(1), 67–79. https://doi.org/10.4239/wjd.v6.i1.67
Kahaly, G. J., & Frommer, L. (2018). Polyglandular autoimmune syndromes. Journal of Endocrinological Investigation, 41(1), 91–98. https://doi.org/10.1007/s40618-017-0740-9
King, D., & Armstrong, M. J. (2019). Overview of Gilbert’s syndrome. Drug and Therapeutics Bulletin, 57(2), 27–31. https://doi.org/10.1136/dtb.2018.000028
Orbach, H., & Shoenfeld, Y. (2007). Hyperprolactinemia and autoimmune diseases. Autoimmunity Reviews, 6(8), 537–542. https://doi.org/10.1016/j.autrev.2006.10.005
Paknys, G., Kondrotas, A. J., & Kėvelaitis, E. (2009). Hašimoto tiroidito rizikos veiksniai ir patogenezė. Medicina (Kaunas), 45(7), 574–583. https://doi.org/10.3390/medicina45070076
Pyzik, A., Grywalska, E., Matyjaszek-Matuszek, B., & Roliński, J. (2015). Immune disorders in Hashimoto’s thyroiditis: What do we know so far? Journal of Immunology Research, 2015. https://doi.org/10.1155/2015/979167
Strassburg, C. P. (2010). Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome). Best Practice and Research: Clinical Gastroenterology, 24(5), 555–571. https://doi.org/10.1016/j.bpg.2010.07.007
Tan, S. Y., Mei Wong, J. L., Sim, Y. J., Wong, S. S., Mohamed Elhassan, S. A., Tan, S. H., Ling Lim, G. P., Rong Tay, N. W., Annan, N. C., Bhattamisra, S. K., & Candasamy, M. (2019). Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 13(1), 364–372. https://doi.org/10.1016/j.dsx.2018.10.008
Tavares, J. V., & Kahwage, A. M. (2019). Síndrome poliglandular autoimune tipo III: uma rara associação entre doença de graves, vitiligo e miastenia gravis. Revista Eletrônica Acervo Saúde, 11(5), e245. https://doi.org/10.25248/reas.e245.2019
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Alissa Pupin Silvério; Gabriela Teixeira Bazuco; Isabela Nicoletti Merotti; Julia Dayrell Beretens ; Simone Caetani Machado; Alessandra Cristina Pupin Silvério
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
